Long-term outcomes after definitive radiotherapy with modern techniques for unresectable soft tissue sarcoma.
(2022) Radiotherapy & Oncology — Vol. 173, n° 1, p. 55-61 (2022)
Files
1-s20-S0167814022022769-maiLong-termoutcomesafterdefinitiveradiotherapy.pdf
Open Access - Adobe PDF
- 493.86 KB
Details
- Authors
- Abstract
- (en) INTRODUCTION: The use of definitive radiotherapy (dRT) in unresectable soft-tissue sarcomas (STS) is still controversial and recent data are scarce. We report clinical results of this therapeutic option. METHODS: We retrospectively included STS patients treated between 2009 and 2020, with dRT for unresectable or with a measurable residual disease after R2 surgery. Response rate, local failure (LF), progression-free survival (PFS) and overall survival (OS) were evaluated. RESULTS: 116 patients with localized/locally advanced STS were treated from 2009 to 2020, with a median age of 71 years (range 18-92). Most tumors were deep-seated (96.6%), grade 2-3 (85.1%), located in the trunk or extremities (74.2%). Helical tomotherapy, volumetric modulated arc therapy, or stereotactic radiotherapy was performed in 39.7%, 19% and 8.6% of patients, respectively. The median equivalent dose in 2 Gy fractions (EQD2) was 60 Gy (IQR 52-65). At first follow-up, 66 (58.9%) and 25 (22%) patients had stable disease and partial response. After a median follow-up of 54.8 months (IQR 40.3-95.4), 3-year LF, PFS and OS were 43.2%, 16.6% and 34%, respectively. Median OS was 21.4 months (95%CI 14-26). The multivariate analysis identified grade 3 and AJCC T3-T4 stage to be associated with both shorter PFS and OS (all p < 0.001). Macroscopically incomplete resection and EQD2 ≥ 64 Gy were associated with better OS (p = 0.016 and p = 0.007). Acute and late severe adverse events occurred in 24 (19.7%) and 5 (4.3%) patients. CONCLUSION: In unresectable STS patients, definitive modern radiotherapy is a safe and effective treatment yielding long term control in selected patients.
- Affiliations
Citations
Allignet, B., Waissi, W., Geets, X., Dufresne, A., Brahmi, M., Ray-Coquard, I., Blay, J.-Y., Bouhamama, A., Meeus, P., Vaz, G., Gouin, F., Moncharmont, C., & Sunyach, M.-P. (2022). Long-term outcomes after definitive radiotherapy with modern techniques for unresectable soft tissue sarcoma. Radiotherapy & Oncology, 173(1), 55-61. https://doi.org/10.1016/j.radonc.2022.05.020 (Original work published 2022)